Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials
Background: We evaluated the time to progression (TTP) and survival outcomes of second-line therapy for metastatic colorectal cancer among adults aged 70 years and older compared with younger adults following progression on first-line clinical trials. Methods: Associations between clinical and disea...
Main Author: | |
---|---|
Other Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | article |
Language: | eng |
Published: |
2022
|
Subjects: | |
Online Access: | https://doi.org/10.1093/jncics/pkac014 |
Country: | Portugal |
Oai: | oai:comum.rcaap.pt:10400.26/40841 |